跳至主要内容
临床试验/NCT06290895
NCT06290895已完成不适用

The Effect of Artificial Oocyte Activation on Blastocysts Rate in Patients with Low Fertilization Rate

Clinique Ovo1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2024年2月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54
试验地点
1
主要终点
Blastocyst rate

研究概览

简要总结

Studies reported that calcium signal deficiency or insufficiency during oocyte activation are related with embryo arrest and blastocyst quality. The utilization of Artificial Oocyte Activation (AOA) is safe and does not increase birth defects, cognition, language and motor skills. AOA is the first line of treatment in patients with globozoospermia (round headed spermatozoa). Poor responders in in-vitro fertilization (IVF) cycles represent a major challenge for fertility specialists and comprises about 10-15% of patients undergoing controlled ovarian hyperstimulation. The absence of synergy between the oocyte and sperm leads to a negative impact on oocyte activation. The European Society of Human and REproduction (ESHRE) recommends AOA in cases with failed fertilization/ low fertilization.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 42 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients with poor or no blastocyst development in their primary cycle
  • Group 1 - second cycle using AOA following the poor blastocyst development cycle
  • Group 2 - second cycle without AOA following the poor development cycle

排除标准

  • All cycles who do not have repeat cycles following the poor blastocyst development cycle

结局指标

主要结局

Blastocyst rate

时间窗: 5 days after oocyte fertilization

Likelihood of an oocyte fertilized to blastocyst stage

次要结局

未报告次要终点

研究者

发起方
Clinique Ovo
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Artificial Oocyte Activation | 临床试验